1-12 of 12
Simon DJ Gibbs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

Simon DJ Gibbs, MBBS, FRACP, FRCPA, Caroline Wong, MBBS, James Hare, MBBS FRACP, Hendrik Zimmet, MBBS FRACP, Jay Hocking, MBBS, FRACP, FRCPA, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Stephen B Ting, MB BS, FRACP, FRCPA, PhD
Journal: Blood
Blood (2016) 128 (22): 3557.
https://doi.org/10.1182/blood.V128.22.3557.3557
Published: 2016
Journal Articles

Seattle Regimen RIC-HSCT in Early-Phase Multiple Myeloma: A Multi-Centre Experience Demonstrating Very Low Treatment-Related Mortality and Rapid Graft-Versus-Myeloma Effect Associated with Graft-Versus-Host Disease

Michael J Shipton, MBChB, BSc, David JM Routledge, MRCP, Neil Bodagh, MBChB, BSc, James Cavet, FRCPath, Eleni Tholouli, Samar Kulkarni, FRCPath, Simon DJ Gibbs
Journal: Blood
Blood (2015) 126 (23): 4355.
https://doi.org/10.1182/blood.V126.23.4355.4355
Published: 2015
Journal Articles

Treatment and Outcome of 267 Patients with IgM-Related AL Amyloidosis

Murielle Roussel, MD, Giovanni Palladini, Simon DJ Gibbs, Christopher P. Venner, MD, Jean-Paul Fermand, Helen J Lachmann, MD, FRCP, Julian D Gillmore, MD, Philip N Hawkins, MD, Giampaolo Merlini, Arnaud Jaccard, Ashutosh Wechalekar, MD
Journal: Blood
Blood (2012) 120 (21): 4074.
https://doi.org/10.1182/blood.V120.21.4074.4074
Published: 2012
Journal Articles

A Matched Comparison of Cyclophosphamide, Bortezomib and Dexamethasone (CVD) Versus Cyclophosphamide, Thalidomide and Dexamethasone (CTD) in the Treatment of Mayo Cardiac Stage III Patients with AL Amyloidosis.

Christopher P Venner, MD, Thirusha Lane, RN, Darren Foard, RN, Lisa Rannigan, RN, Shameem Mahmood, MBBCh. FRCPath, Simon DJ Gibbs, Jennifer Pinney, MD, Sanjay Banypersad, MD, Jason Dungu, Carol Whelan, Helen Lachmann, MD, Julian D Gillmore, MD, Philip N Hawkins, MD, Ashutosh Wechalekar, MD
Journal: Blood
Blood (2012) 120 (21): 2966.
https://doi.org/10.1182/blood.V120.21.2966.2966
Published: 2012
Journal Articles

Complete and Very Good Partial Responses Are Attainable Endpoints in Elderly Patients (>75 years) with AL Amyloidosis and Are Associated with Improved Overall Survival,

Christopher P. Venner, MD, Julian D Gillmore, Thirusha Lane, RN, Darren Foard, RN, Lisa Rannigan, RN, Simon DJ Gibbs, Jennifer Pinney, MD, Carol Whelan, Helen Lachmann, MD, Philip N Hawkins, Ashutosh Wechalekar, MD
Journal: Blood
Blood (2011) 118 (21): 3975.
https://doi.org/10.1182/blood.V118.21.3975.3975
Published: 2011
Journal Articles

Cyclophosphamide, Bortezomib and Dexamethasone (CVD) Therapy in AL Amyloidosis Is Associated with High Clonal Response Rates and Prolonged Progression Free Survival,

Christopher P. Venner, MD, Julian D Gillmore, Thirusha Lane, RN, Darren Foard, RN, Lisa Rannigan, RN, Simon DJ Gibbs, Jennifer Pinney, MD, Carol Whelan, Helen Lachmann, MD, Philip N Hawkins, Ashutosh Wechalekar, MD
Journal: Blood
Blood (2011) 118 (21): 3978.
https://doi.org/10.1182/blood.V118.21.3978.3978
Published: 2011
Journal Articles

A European Collaborative Study of Treatment Outcomes In 428 Patients with Systemic AL Amyloidosis

Ashutosh D Wechalekar, Efstathios Kastritis, Giampaolo Merlini, Philip N Hawkins, Meletios A. Dimopoulos, Julian D Gillmore, Simon DJ Gibbs, Giovanni Palladini
Journal: Blood
Blood (2010) 116 (21): 988.
https://doi.org/10.1182/blood.V116.21.988.988
Published: 2010
Journal Articles

Transient Post Chemotherapy Rise in NT Pro-BNP in AL Amyloidosis : Implications for Organ Response Assessment.

Simon DJ Gibbs, Marna De Cruz, Prayman T Sattianayagam, Helen J Lachmann, Julian D Gillmore, Philip N Hawkins, Ashutosh D Wechalekar
Journal: Blood
Blood (2009) 114 (22): 1791.
https://doi.org/10.1182/blood.V114.22.1791.1791
Published: 2009
Journal Articles

Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Versus Melphalan Plus Dexamethasone (MD) for Newly-Diagnosed Systemic AL Amyloidosis – Results From the UK Amyloidosis Treatment Trial.

Julian Gillmore, Kim Cocks, Simon DJ Gibbs, Prayman T Sattianayagam, Thirusha Lane, Helen Lachmann, Stephen Schey, James D. Cavenagh, Heather Oakervee, Gareth J Morgan, Atul B Mehta, Suzan Bourne, E. Skinner, G. Booth, Philip N Hawkins, Ashutosh D Wechalekar
Journal: Blood
Blood (2009) 114 (22): 2869.
https://doi.org/10.1182/blood.V114.22.2869.2869
Published: 2009
Journal Articles

In AL Amyloidosis, Both Oral Melphalan and Dexamethasone (Mel-Dex) and Risk-Adapted Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Have Similar Efficacy as Upfront Treatment.

Simon DJ Gibbs, Julian D Gillmore, Prayman T Sattianayagam, Mark Offer, Helen J Lachmann, Philip N Hawkins, Ashutosh D Wechalekar
Journal: Blood
Blood (2009) 114 (22): 745.
https://doi.org/10.1182/blood.V114.22.745.745
Published: 2009
Journal Articles

Is There a Role for Thalidomide Maintenance in the Treatment of AL Amyloidosis?.

Simon DJ Gibbs, Prayman T Sattianayagam, Julian D Gillmore, Mark Offer, Helen J Lachmann, Philip N Hawkins, Ashutosh D Wechalekar
Journal: Blood
Blood (2009) 114 (22): 1863.
https://doi.org/10.1182/blood.V114.22.1863.1863
Published: 2009
Journal Articles

A New Staging System for AL Amyloidosis Incorporating Serum Free Light Chains, cardiac Troponin-T and NT-ProBNP.

Ashutosh D Wechalekar, Nancy L Wassef, Simon DJ Gibbs, Julian Gillmore, Felicia Dike, Helen Lachmann, Prayman Sattianayagam, Arthur Bradwell, Philip N Hawkins
Journal: Blood
Blood (2009) 114 (22): 2796.
https://doi.org/10.1182/blood.V114.22.2796.2796
Published: 2009